Orthofix International updates FY 2017 earnings guidance: 5 insights

Biologics

Orthofix International updated its fiscal year 2017 earnings guidance, according to The Ledger Gazette.

Here are five insights:

 

1. Orthofix reported earnings per share guidance of $1.54 to $1.63.

 

2. The company's revenue guidance is $428 million to $431 million.

 

3. Orthofix's stock carries a market capitalization of $976.27 million.  

 

4. The company's stock has a P/E ratio of $125.83.

 

5. The 50-day moving average price is $49.01 and the 200-day moving average is $45.60.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers